Cargando…

Rapid Assessment of Binding Affinity of SARS-COV-2 Spike Protein to the Human Angiotensin-Converting Enzyme 2 Receptor and to Neutralizing Biomolecules Based on Computer Simulations

SARS-CoV-2 infects humans and causes Coronavirus disease 2019 (COVID-19). The S1 domain of the spike glycoprotein of SARS-CoV-2 binds to human angiotensin-converting enzyme 2 (hACE2) via its receptor-binding domain, while the S2 domain facilitates fusion between the virus and the host cell membrane...

Descripción completa

Detalles Bibliográficos
Autores principales: Buratto, Damiano, Saxena, Abhishek, Ji, Qun, Yang, Guang, Pantano, Sergio, Zonta, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632240/
https://www.ncbi.nlm.nih.gov/pubmed/34858396
http://dx.doi.org/10.3389/fimmu.2021.730099
_version_ 1784607719988133888
author Buratto, Damiano
Saxena, Abhishek
Ji, Qun
Yang, Guang
Pantano, Sergio
Zonta, Francesco
author_facet Buratto, Damiano
Saxena, Abhishek
Ji, Qun
Yang, Guang
Pantano, Sergio
Zonta, Francesco
author_sort Buratto, Damiano
collection PubMed
description SARS-CoV-2 infects humans and causes Coronavirus disease 2019 (COVID-19). The S1 domain of the spike glycoprotein of SARS-CoV-2 binds to human angiotensin-converting enzyme 2 (hACE2) via its receptor-binding domain, while the S2 domain facilitates fusion between the virus and the host cell membrane for entry. The spike glycoprotein of circulating SARS-CoV-2 genomes is a mutation hotspot. Some mutations may affect the binding affinity for hACE2, while others may modulate S-glycoprotein expression, or they could result in a virus that can escape from antibodies generated by infection with the original variant or by vaccination. Since a large number of variants are emerging, it is of vital importance to be able to rapidly assess their characteristics: while changes of binding affinity alone do not always cause direct advantages for the virus, they still can provide important insights on where the evolutionary pressure is directed. Here, we propose a simple and cost-effective computational protocol based on Molecular Dynamics simulations to rapidly screen the ability of mutated spike protein to bind to the hACE2 receptor and selected neutralizing biomolecules. Our results show that it is possible to achieve rapid and reliable predictions of binding affinities. A similar approach can be used to perform preliminary screenings of the potential effects of S-RBD mutations, helping to prioritize the more time-consuming and expensive experimental work.
format Online
Article
Text
id pubmed-8632240
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86322402021-12-01 Rapid Assessment of Binding Affinity of SARS-COV-2 Spike Protein to the Human Angiotensin-Converting Enzyme 2 Receptor and to Neutralizing Biomolecules Based on Computer Simulations Buratto, Damiano Saxena, Abhishek Ji, Qun Yang, Guang Pantano, Sergio Zonta, Francesco Front Immunol Immunology SARS-CoV-2 infects humans and causes Coronavirus disease 2019 (COVID-19). The S1 domain of the spike glycoprotein of SARS-CoV-2 binds to human angiotensin-converting enzyme 2 (hACE2) via its receptor-binding domain, while the S2 domain facilitates fusion between the virus and the host cell membrane for entry. The spike glycoprotein of circulating SARS-CoV-2 genomes is a mutation hotspot. Some mutations may affect the binding affinity for hACE2, while others may modulate S-glycoprotein expression, or they could result in a virus that can escape from antibodies generated by infection with the original variant or by vaccination. Since a large number of variants are emerging, it is of vital importance to be able to rapidly assess their characteristics: while changes of binding affinity alone do not always cause direct advantages for the virus, they still can provide important insights on where the evolutionary pressure is directed. Here, we propose a simple and cost-effective computational protocol based on Molecular Dynamics simulations to rapidly screen the ability of mutated spike protein to bind to the hACE2 receptor and selected neutralizing biomolecules. Our results show that it is possible to achieve rapid and reliable predictions of binding affinities. A similar approach can be used to perform preliminary screenings of the potential effects of S-RBD mutations, helping to prioritize the more time-consuming and expensive experimental work. Frontiers Media S.A. 2021-11-11 /pmc/articles/PMC8632240/ /pubmed/34858396 http://dx.doi.org/10.3389/fimmu.2021.730099 Text en Copyright © 2021 Buratto, Saxena, Ji, Yang, Pantano and Zonta https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Buratto, Damiano
Saxena, Abhishek
Ji, Qun
Yang, Guang
Pantano, Sergio
Zonta, Francesco
Rapid Assessment of Binding Affinity of SARS-COV-2 Spike Protein to the Human Angiotensin-Converting Enzyme 2 Receptor and to Neutralizing Biomolecules Based on Computer Simulations
title Rapid Assessment of Binding Affinity of SARS-COV-2 Spike Protein to the Human Angiotensin-Converting Enzyme 2 Receptor and to Neutralizing Biomolecules Based on Computer Simulations
title_full Rapid Assessment of Binding Affinity of SARS-COV-2 Spike Protein to the Human Angiotensin-Converting Enzyme 2 Receptor and to Neutralizing Biomolecules Based on Computer Simulations
title_fullStr Rapid Assessment of Binding Affinity of SARS-COV-2 Spike Protein to the Human Angiotensin-Converting Enzyme 2 Receptor and to Neutralizing Biomolecules Based on Computer Simulations
title_full_unstemmed Rapid Assessment of Binding Affinity of SARS-COV-2 Spike Protein to the Human Angiotensin-Converting Enzyme 2 Receptor and to Neutralizing Biomolecules Based on Computer Simulations
title_short Rapid Assessment of Binding Affinity of SARS-COV-2 Spike Protein to the Human Angiotensin-Converting Enzyme 2 Receptor and to Neutralizing Biomolecules Based on Computer Simulations
title_sort rapid assessment of binding affinity of sars-cov-2 spike protein to the human angiotensin-converting enzyme 2 receptor and to neutralizing biomolecules based on computer simulations
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632240/
https://www.ncbi.nlm.nih.gov/pubmed/34858396
http://dx.doi.org/10.3389/fimmu.2021.730099
work_keys_str_mv AT burattodamiano rapidassessmentofbindingaffinityofsarscov2spikeproteintothehumanangiotensinconvertingenzyme2receptorandtoneutralizingbiomoleculesbasedoncomputersimulations
AT saxenaabhishek rapidassessmentofbindingaffinityofsarscov2spikeproteintothehumanangiotensinconvertingenzyme2receptorandtoneutralizingbiomoleculesbasedoncomputersimulations
AT jiqun rapidassessmentofbindingaffinityofsarscov2spikeproteintothehumanangiotensinconvertingenzyme2receptorandtoneutralizingbiomoleculesbasedoncomputersimulations
AT yangguang rapidassessmentofbindingaffinityofsarscov2spikeproteintothehumanangiotensinconvertingenzyme2receptorandtoneutralizingbiomoleculesbasedoncomputersimulations
AT pantanosergio rapidassessmentofbindingaffinityofsarscov2spikeproteintothehumanangiotensinconvertingenzyme2receptorandtoneutralizingbiomoleculesbasedoncomputersimulations
AT zontafrancesco rapidassessmentofbindingaffinityofsarscov2spikeproteintothehumanangiotensinconvertingenzyme2receptorandtoneutralizingbiomoleculesbasedoncomputersimulations